drugset / Trial / NCT00684047

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

NCT00684047

Phase 2/3 Completed 239 enrolled Grifols, S.A.
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the safety and hemostasis effectiveness of human plasma-derived fibrin sealant Grifols (FS Grifols) in peripheral vascular surgery.

Timeline

Start
2008-02
Primary completion
2014-03
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrin Sealant Grifols Protein / enzyme biologic